Detection and localization of surgically resectable cancers with a multi-analyte blood test Journal Article


Authors: Cohen, J. D.; Li, L.; Wang, Y.; Thoburn, C.; Afsari, B.; Danilova, L.; Douville, C.; Javed, A. A.; Wong, F.; Mattox, A.; Hruban, R. H.; Wolfgang, C. L.; Goggins, M. G.; Dal Molin, M.; Wang, T. L.; Roden, R.; Klein, A. P.; Ptak, J.; Dobbyn, L.; Schaefer, J.; Silliman, N.; Popoli, M.; Vogelstein, J. T.; Browne, J. D.; Schoen, R. E.; Brand, R. E.; Tie, J.; Gibbs, P.; Wong, H. L.; Mansfield, A. S.; Jen, J.; Hanash, S. M.; Falconi, M.; Allen, P. J.; Zhou, S.; Bettegowda, C.; Diaz, L. A. Jr; Tomasetti, C.; Kinzler, K. W.; Vogelstein, B.; Lennon, A. M.; Papadopoulos, N.
Article Title: Detection and localization of surgically resectable cancers with a multi-analyte blood test
Abstract: Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. We applied this test, called CancerSEEK, to 1005 patients with nonmetastatic, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast. CancerSEEK tests were positive in a median of 70% of the eight cancer types. The sensitivities ranged from 69 to 98% for the detection of five cancer types (ovary, liver, stomach, pancreas, and esophagus) for which there are no screening tests available for average-risk individuals. The specificity of CancerSEEK was greater than 99%: only 7 of 812 healthy controls scored positive. In addition, CancerSEEK localized the cancer to a small number of anatomic sites in a median of 83% of the patients. © 2017 The Authors.
Journal Title: Science
Volume: 359
Issue: 6378
ISSN: 0036-8075
Publisher: American Association for the Advancement of Science  
Date Published: 2018-02-23
Start Page: 926
End Page: 930
Language: English
DOI: 10.1126/science.aar3247
PROVIDER: scopus
PUBMED: 29348365
PMCID: PMC6080308
DOI/URL:
Notes: Article -- Export Date: 1 March 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Peter Allen
    501 Allen